Review: taking Ritalin and Suboxone together


Summary

Drug interactions are reported among people who take Ritalin and Suboxone together. This review analyzes the effectiveness and drug interactions between Ritalin and Suboxone. It is created by eHealthMe based on reports of 83 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Ritalin and Suboxone >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Ritalin

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Ritalin 12,382 users)

Suboxone

Suboxone has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in drug dependence. (latest outcomes from Suboxone 10,832 users)

On Aug, 26, 2016

83 people who take Ritalin, Suboxone are studied.


Number of reports submitted per year:

Ritalin and Suboxone drug interactions.

Drug effectiveness over time:

Ritalin:
  • < 1 month: 28.0% - (2 of 7 people)
  • 1 - 6 months: 75.0% - (3 of 4 people)
  • 6 - 12 months: 75.0% - (3 of 4 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 66.0% - (2 of 3 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Suboxone:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 40.0% - (2 of 5 people)
  • 6 - 12 months: 66.0% - (2 of 3 people)
  • 1 - 2 years: 83.0% - (5 of 6 people)
  • 2 - 5 years: 100.0% - (3 of 3 people)
  • 5 - 10 years: 100.0% - (2 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Ritalin:
  • female: 61.0% - (8 of 13 people)
  • male: 50.0% - (4 of 8 people)
Suboxone:
  • female: 75.0% - (9 of 12 people)
  • male: 75.0% - (6 of 8 people)

Drug effectiveness by age:

Ritalin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 57.0% - (4 of 7 people)
  • 30-39: 37.0% - (3 of 8 people)
  • 40-49: 66.0% - (2 of 3 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 100.0% - (1 of 1 people)
Suboxone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 71.0% - (5 of 7 people)
  • 30-39: 57.0% - (4 of 7 people)
  • 40-49: 100.0% - (3 of 3 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • accidental exposure
  • arthralgia
  • asthma
  • cellulitis
  • colitis
  • fibromyalgia
  • foetal exposure during pregnancy
  • listless
  • overdose
  • pleuritic pain
1 - 6 months:
  • skin hyperpigmentation
  • suicidal ideation
  • asthma
  • carpal tunnel syndrome
  • cellulitis
  • colitis
  • depression
  • drug withdrawal syndrome
  • fibromyalgia
  • fluid retention
6 - 12 months:
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • flushing
  • irregular sleep phase
  • irritability
  • muscle cramps
  • pitting oedema
  • sweating - excessive
  • extensive interdialytic weight gain
  • sweating fever
  • carpal tunnel syndrome
1 - 2 years:
  • skin hyperpigmentation
  • drowsiness
  • depression aggravated
  • dizziness
  • drug abuse
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • headache
  • hunger
  • insomnia
  • nausea
2 - 5 years:
  • hives
  • depression aggravated
  • dizziness
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • headache
  • hunger
  • nausea
  • serum serotonin decreased
  • tired eyes
  • weight increased
5 - 10 years:
  • dark circles under eyes
  • extensive interdialytic weight gain
  • sweating fever
  • abnormal sleep-related event
  • decreased eye contact
  • gastrooesophageal reflux disease
  • hiatus hernia
  • impaired gastric emptying
  • impulsive behaviour
  • inappropriate affect
not specified:
  • malaise
  • nausea
  • vomiting
  • diabetes mellitus
  • foetal exposure during pregnancy
  • gastrooesophageal reflux disease
  • lactic acidosis
  • mouth ulceration
  • anxiety
  • drug abuse

Most common drug interactions by gender *:

female:
  • gastrooesophageal reflux disease
  • malaise
  • accidental exposure
  • diabetes mellitus
  • lactic acidosis
  • listless
  • maternal exposure during pregnancy
  • mouth ulceration
  • nausea
  • vomiting
male:
  • dyspnoea
  • insomnia
  • status asthmaticus
  • exhibitionism
  • judgement impaired
  • obsessive-compulsive disorder
  • polydipsia
  • suspiciousness
  • anxiety
  • cyanosis

Most common drug interactions by age *:

2-9:
  • insomnia
  • anxiety
  • drooling
  • drug administration error
  • drug ineffective
  • hallucinations, mixed
  • lip swelling
  • product taste abnormal
  • urticaria
10-19:
  • death
20-29:
  • malaise
  • gastrooesophageal reflux disease
  • diabetes mellitus
  • dyspnoea
  • lactic acidosis
  • mouth ulceration
  • status asthmaticus
  • cyanosis
  • dilatation ventricular
  • drug abuse
30-39:
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • exhibitionism
  • flushing
  • irregular sleep phase
  • irritability
  • judgement impaired
  • muscle cramps
  • obsessive-compulsive disorder
  • pitting oedema
  • polydipsia
40-49:
  • skin hyperpigmentation
  • nausea
  • placenta praevia
  • premature delivery
  • vomiting
  • amnesia
  • anxiety
  • blood pressure increased
  • confusional state
  • death
50-59:
  • arthralgia
  • asthma
  • cellulitis
  • colitis
  • dark circles under eyes
  • extensive interdialytic weight gain
  • fibromyalgia
  • overdose
  • pleuritic pain
  • sweating fever
60+:
  • nausea
  • convulsion
  • dehydration
  • diabetes mellitus
  • dizziness
  • drug ineffective
  • electrolyte imbalance
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • gastrooesophageal reflux disease
  • headache

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Ritalin and Suboxone?

Can you answer these questions?

More questions for: Ritalin, Suboxone

You may be interested in these reviews

More reviews for: Ritalin, Suboxone

On eHealthMe, Ritalin (methylphenidate hydrochloride) is often used to treat attention deficit hyperactivity disorder. Suboxone (buprenorphine hydrochloride; naloxone hydrochloride) is often used to treat drug dependence. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.